{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:49:10Z","timestamp":1790740150516,"version":"4.1.0"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejps.2017.11.001","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T12:01:32Z","timestamp":1510142492000},"page":"8-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Renal organic anion transporters in drug\u2013drug interactions and diseases"],"prefix":"10.1016","volume":"112","author":[{"given":"Xiaokui","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0699-8452","authenticated-orcid":false,"given":"Kexin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2017.11.001_bb0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/jpet.115.231647","article-title":"Stronger Uricosuric effects of the novel selective URAT1 inhibitor UR-1102 lowered plasma urate in tufted capuchin monkeys to a greater extent than Benzbromarone","volume":"357","author":"Ahn","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.11.001_bb0010","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1053\/ajkd.2003.50075","article-title":"Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis","volume":"41","author":"Aoyama","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejps.2017.11.001_bb0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/BOR.0000000000000035","article-title":"Uricosuric drugs: the once and future therapy for hyperuricemia?","volume":"26","author":"Bach","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000363251","article-title":"Differential effect of COX1 and COX2 inhibitors on renal outcomes following ischemic acute kidney injury","volume":"40","author":"Bischoff","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/phy2.243","article-title":"PAH clearance after renal ischemia and reperfusion is a function of impaired expression of basolateral Oat1 and Oat3","volume":"2","author":"Bischoff","year":"2014","journal-title":"Physiol Rep"},{"key":"10.1016\/j.ejps.2017.11.001_bb0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000181953","article-title":"Renal function in rats with acute medullary injury","volume":"26","author":"Brown","year":"1980","journal-title":"Nephron"},{"key":"10.1016\/j.ejps.2017.11.001_bb0035","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00204-013-1062-0","article-title":"Organic anion transporter 5 (Oat5) renal expression and urinary excretion in rats treated with cisplatin: a potential biomarker of cisplatin-induced nephrotoxicity","volume":"87","author":"Bulacio","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000351703","article-title":"Beneficial effect of rutin on oxonate-induced hyperuricemia and renal dysfunction in mice","volume":"92","author":"Chen","year":"2013","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejps.2017.11.001_bb0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jep.2015.08.043","article-title":"Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice","volume":"175","author":"Chen","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/15384047.2014.987062","article-title":"Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway","volume":"16","author":"Chen","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejps.2017.11.001_bb0055","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1124\/dmd.114.058529","article-title":"Proton pump inhibitors inhibit methotrexate transport by renal basolateral organic anion transporter hOAT3","volume":"42","author":"Chioukh","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.11.001_bb0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/bdd.694","article-title":"Effects of 1alpha,25-dihydroxyvitamin D3 on transporters and enzymes of the rat intestine and kidney in vivo","volume":"31","author":"Chow","year":"2010","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2017.11.001_bb0065","series-title":"Vitro and In Vivo Assessment of Renal Drug Transporters in the Disposition of Mesna and Dimesna. J. Clin. Pharmacol","first-page":"530","volume":"Vol. 52","author":"Cutler","year":"2012"},{"key":"10.1016\/j.ejps.2017.11.001_bb0070","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1124\/jpet.105.085613","article-title":"Renal clearance of endogenous hippurate correlates with expression levels of renal organic anion transporters in uremic rats","volume":"314","author":"Deguchi","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.11.001_bb0075","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/jpet.111.180984","article-title":"Physiological and molecular characterization of aristolochic acid transport by the kidney","volume":"338","author":"Dickman","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.11.001_bb0080","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3724\/SP.J.1009.2013.00214","article-title":"Wuling san ameliorates urate under-excretion and renal dysfunction in hyperuricemic mice","volume":"11","author":"Ding","year":"2013","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejps.2017.11.001_bb0085","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1002\/jps.24489","article-title":"The use of transporter probe drug cocktails for the assessment of transporter-based drug-drug interactions in a clinical setting-proposal of a four component transporter cocktail","volume":"104","author":"Ebner","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.11.001_bb0090","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1254\/jphs.94.297","article-title":"Human organic anion transporter 4 is a renal apical organic anion\/dicarboxylate exchanger in the proximal tubules","volume":"94","author":"Ekaratanawong","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejps.2017.11.001_bb0095","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1124\/pr.111.004614","article-title":"Organic anion transporters and their implications in pharmacotherapy","volume":"64","author":"Emami Riedmaier","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2017.11.001_bb0100","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1152\/physiolgenomics.00207.2007","article-title":"Multiple organic anion transporters contribute to net renal excretion of uric acid","volume":"33","author":"Eraly","year":"2008","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.ejps.2017.11.001_bb0105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12011-014-9914-x","article-title":"Effect of lycopene against cisplatin-induced acute renal injury in rats: organic anion and cation transporters evaluation","volume":"158","author":"Erman","year":"2014","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.ejps.2017.11.001_bb0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1872312810666160411144358","article-title":"Rate-determining and rate-limiting steps in the clearance and excretion of a potent and selective p21-activated kinase inhibitor: a case study of rapid hepatic uptake and slow elimination in rat","volume":"10","author":"Fan","year":"2016","journal-title":"Drug Metab Lett"},{"key":"10.1016\/j.ejps.2017.11.001_bb0115","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 7","key":"10.1016\/j.ejps.2017.11.001_bb0120","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1002\/jcph.702","article-title":"Evaluation and quantitative prediction of renal transporter-mediated drug-drug interactions","volume":"56","author":"Feng","year":"2016","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejps.2015.10.008","article-title":"Bezafibrate-mizoribine interaction: involvement of organic anion transporters OAT1 and OAT3 in rats","volume":"81","author":"Feng","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.11.001_bb0130","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1124\/jpet.111.187732","article-title":"Vivo kinetics of indoxyl sulfate in humans and its renal interaction with angiotensin-converting enzyme inhibitor quinapril in rats","volume":"341","author":"Fujita","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.11.001_bb0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2017.11.001_bb0140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cpt196893345","article-title":"Apparent effect of probenecid on the distribution of penicillins in man","volume":"9","author":"Gibaldi","year":"1968","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2017.11.001_bb0145","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2133\/dmpk.DMPK-11-RG-089","article-title":"Peptide cotransporter 1 in intestine and organic anion transporters in kidney are targets of interaction between JBP485 and lisinopril in rats","volume":"27","author":"Guo","year":"2012","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2017.11.001_bb0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.taap.2013.04.029","article-title":"JBP485 improves gentamicin-induced acute renal failure by regulating the expression and function of Oat1 and Oat3 in rats","volume":"271","author":"Guo","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0155","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1159\/000438517","article-title":"Chinese herbal formulas Si-Wu-tang and Er-Miao-san synergistically ameliorated hyperuricemia and renal impairment in rats induced by adenine and potassium Oxonate","volume":"37","author":"Guo","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejps.2017.11.001_bb0160","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0006-2952(03)00466-0","article-title":"Decreased activity of basolateral organic ion transports in hyperuricemic rat kidney: roles of organic ion transporters, rOAT1, rOAT3 and rOCT2","volume":"66","author":"Habu","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0165","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.bcp.2004.12.004","article-title":"Restored expression and activity of organic ion transporters rOAT1, rOAT3 and rOCT2 after hyperuricemia in the rat kidney","volume":"69","author":"Habu","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0170","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1681\/ASN.2007010106","article-title":"Torasemide transport by organic anion transporters contributes to hyperuricemia","volume":"18","author":"Hagos","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0175","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1681\/ASN.2006040415","article-title":"Human renal organic anion transporter 4 operates as an asymmetric urate transporter","volume":"18","author":"Hagos","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0180","first-page":"647","article-title":"Drug therapy in patients with chronic renal failure","volume":"107","author":"Hartmann","year":"2010","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.ejps.2017.11.001_bb0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.fitote.2015.06.002","article-title":"Pallidifloside D from Smilax Riparia enhanced allopurinol effects in hyperuricemia mice","volume":"105","author":"Hou","year":"2015","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejps.2017.11.001_bb0190","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1021\/acs.molpharmaceut.6b00332","article-title":"Identification and quantitative assessment of uremic solutes as inhibitors of renal organic anion transporters, OAT1 and OAT3","volume":"13","author":"Hsueh","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2017.11.001_bb0195","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00394-011-0243-y","article-title":"Quercetin regulates organic ion transporter and uromodulin expression and improves renal function in hyperuricemic mice","volume":"51","author":"Hu","year":"2012","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.ejps.2017.11.001_bb0200","doi-asserted-by":"crossref","first-page":"8976","DOI":"10.3390\/molecules18088976","article-title":"Fructus gardenia extract ameliorates oxonate-induced hyperuricemia with renal dysfunction in mice by regulating organic ion transporters and mOIT3","volume":"18","author":"Hu","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2017.11.001_bb0205","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jep.2012.04.052","article-title":"Anti-hyperuricemic and nephroprotective effects of modified Simiao decoction in hyperuricemic mice","volume":"142","author":"Hua","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0210","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-0035-1558212","article-title":"Hypouricemic and Nephroprotective effects of Emodinol in Oxonate-induced Hyperuricemic mice are mediated by organic ion transporters and OIT3","volume":"82","author":"Hui","year":"2016","journal-title":"Planta Med."},{"key":"10.1016\/j.ejps.2017.11.001_bb0215","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ejps.2013.08.010","article-title":"Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin","volume":"50","author":"Huo","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.11.001_bb0220","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jps.23805","article-title":"Inhibitory effect of valsartan on the intestinal absorption and renal excretion of bestatin in rats","volume":"103","author":"Huo","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.11.001_bb0225","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11926-016-0587-7","article-title":"Urate handling in the human body","volume":"18","author":"Hyndman","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.ejps.2017.11.001_bb0230","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1124\/dmd.116.070722","article-title":"Lansoprazole exacerbates Pemetrexed-mediated hematologic toxicity by competitive inhibition of renal basolateral human organic anion transporter 3","volume":"44","author":"Ikemura","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.11.001_bb0235","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/dmd.113.055475","article-title":"6beta-Hydroxycortisol is an endogenous probe for evaluation of drug-drug interactions involving a multispecific renal organic anion transporter, OAT3\/SLC22A8, in healthy subjects","volume":"42","author":"Imamura","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.11.001_bb0240","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ijpharm.2015.09.042","article-title":"Enhancement effect of resveratrol on the intestinal absorption of bestatin by regulating PEPT1, MDR1 and MRP2 in vivo and in vitro","volume":"495","author":"Jia","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.11.001_bb0245","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.taap.2016.06.030","article-title":"P-gp, MRP2 and OAT1\/OAT3 mediate the drug-drug interaction between resveratrol and methotrexate","volume":"306","author":"Jia","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0250","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1124\/jpet.111.187161","article-title":"Regulation of tissue-specific expression of renal organic anion transporters by hepatocyte nuclear factor 1 alpha\/beta and DNA methylation","volume":"340","author":"Jin","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.11.001_bb0255","doi-asserted-by":"crossref","unstructured":"Kim, Y.C., Kim, I.B., Noh, C.K., Quach, H.P., Yoon, I.S., Chow, E.C., Kim, M., Jin, H.E., Cho, K.H., Chung, S.J., Pang, K.S., Maeng, H.J., 2014. Effects of 1alpha,25-dihydroxyvitamin D3, the natural vitamin D receptor ligand, on the pharmacokinetics of cefdinir and cefadroxil, organic anion transporter substrates, in rat. J. Pharm. Sci. 103, 3793\u20133805.","DOI":"10.1002\/jps.24195"},{"key":"10.1016\/j.ejps.2017.11.001_bb0260","doi-asserted-by":"crossref","first-page":"F552","DOI":"10.1152\/ajprenal.00341.2011","article-title":"Liver X receptor activation downregulates organic anion transporter 1 (OAT1) in the renal proximal tubule","volume":"302","author":"Kittayaruksakul","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0265","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1124\/dmd.108.022418","article-title":"High-affinity interaction of sartans with H+\/peptide transporters","volume":"37","author":"Knutter","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.11.001_bb0270","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jep.2015.01.013","article-title":"The molecular insight into the antihyperuricemic and renoprotective effect of Shuang qi gout capsule in mice","volume":"163","author":"Kodithuwakku","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0275","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.mam.2012.10.010","article-title":"The SLC22 family with transporters of organic cations, anions and zwitterions","volume":"34","author":"Koepsell","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.ejps.2017.11.001_bb0280","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/jps.23433","article-title":"Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure","volume":"102","author":"Komazawa","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.11.001_bb0285","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1124\/dmd.116.074492","article-title":"Increased plasma exposures of conjugated metabolites of Morinidazole in renal failure patients: a critical role of uremic toxins","volume":"45","author":"Kong","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.11.001_bb0290","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1124\/pr.113.007518","article-title":"Transporters and drug-drug interactions: important determinants of drug disposition and effects","volume":"65","author":"Konig","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2017.11.001_bb0295","doi-asserted-by":"crossref","unstructured":"Kottgen, A., Albrecht, E., Teumer, A., Vitart, V., Krumsiek, J., Hundertmark, C., Pistis, G., Ruggiero, D., O'Seaghdha, C.M., Haller, T., Yang, Q., Tanaka, T., Johnson, A.D., Kutalik, Z., Smith, A.V., Shi, J., Struchalin, M., Middelberg, R.P., Brown, M.J., Gaffo, A.L., Pirastu, N., Li, G., Hayward, C., Zemunik, T., Huffman, J., Yengo, L., Zhao, J.H., Demirkan, A., Feitosa, M.F., Liu, X., Malerba, G., Lopez, L.M., van der Harst, P., Li, X., Kleber, M.E., Hicks, A.A., Nolte, I.M., Johansson, A., Murgia, F., Wild, S.H., Bakker, S.J., Peden, J.F., Dehghan, A., Steri, M., Tenesa, A., Lagou, V., Salo, P., Mangino, M., Rose, L.M., Lehtimaki, T., Woodward, O.M., Okada, Y., Tin, A., Muller, C., Oldmeadow, C., Putku, M., Czamara, D., Kraft, P., Frogheri, L., Thun, G.A., Grotevendt, A., Gislason, G.K., Harris, T.B., Launer, L.J., McArdle, P., Shuldiner, A.R., Boerwinkle, E., Coresh, J., Schmidt, H., Schallert, M., Martin, N.G., Montgomery, G.W., Kubo, M., Nakamura, Y., Tanaka, T., Munroe, P.B., Samani, N.J., Jacobs, D.R., Jr., Liu, K., D'Adamo, P., Ulivi, S., Rotter, J.I., Psaty, B.M., Vollenweider, P., Waeber, G., Campbell, S., Devuyst, O., Navarro, P., Kolcic, I., Hastie, N., Balkau, B., Froguel, P., Esko, T., Salumets, A., Khaw, K.T., Langenberg, C., Wareham, N.J., Isaacs, A., Kraja, A., Zhang, Q., Wild, P.S., Scott, R.J., Holliday, E.G., Org, E., Viigimaa, M., Bandinelli, S., Metter, J.E., Lupo, A., Trabetti, E., Sorice, R., Doring, A., Lattka, E., Strauch, K., Theis, F., Waldenberger, M., Wichmann, H.E., Davies, G., Gow, A.J., Bruinenberg, M., Stolk, R.P., Kooner, J.S., Zhang, W., Winkelmann, B.R., Boehm, B.O., Lucae, S., Penninx, B.W., Smit, J.H., Curhan, G., Mudgal, P., Plenge, R.M., Portas, L., Persico, I., Kirin, M., Wilson, J.F., Mateo Leach, I., van Gilst, W.H., Goel, A., Ongen, H., Hofman, A., Rivadeneira, F., Uitterlinden, A.G., Imboden, M., von Eckardstein, A., Cucca, F., Nagaraja, R., Piras, M.G., Nauck, M., Schurmann, C., Budde, K., Ernst, F., Farrington, S.M., Theodoratou, E., Prokopenko, I., Stumvoll, M., Jula, A., Perola, M., Salomaa, V., Shin, S.Y., Spector, T.D., Sala, C., Ridker, P.M., Kahonen, M., Viikari, J., Hengstenberg, C., Nelson, C.P., Meschia, J.F., Nalls, M.A., Sharma, P., Singleton, A.B., Kamatani, N., Zeller, T., Burnier, M., Attia, J., Laan, M., Klopp, N., Hillege, H.L., Kloiber, S., Choi, H., Pirastu, M., Tore, S., Probst-Hensch, N.M., Volzke, H., Gudnason, V., Parsa, A., Schmidt, R., Whitfield, J.B., Fornage, M., Gasparini, P., Siscovick, D.S., Polasek, O., Campbell, H., Rudan, I., Bouatia-Naji, N., Metspalu, A., Loos, R.J., van Duijn, C.M., Borecki, I.B., Ferrucci, L., Gambaro, G., Deary, I.J., Wolffenbuttel, B.H., Chambers, J.C., Marz, W., Pramstaller, P.P., Snieder, H., Gyllensten, U., Wright, A.F., Navis, G., Watkins, H., Witteman, J.C., Sanna, S., Schipf, S., Dunlop, M.G., Tonjes, A., Ripatti, S., Soranzo, N., Toniolo, D., Chasman, D.I., Raitakari, O., Kao, W.H., Ciullo, M., Fox, C.S., Caulfield, M., Bochud, M., Gieger, C., 2013. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat. Genet. 45, 145\u2013154.","DOI":"10.1038\/ng.2500"},{"key":"10.1016\/j.ejps.2017.11.001_bb0300","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/00498254.2014.1000430","article-title":"Evaluation of drug-drug interaction between the novel cPLA2 inhibitor AK106-001616 and methotrexate in rheumatoid arthritis patients","volume":"45","author":"Kozaki","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejps.2017.11.001_bb0305","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2133\/dmpk.24.37","article-title":"Vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney","volume":"24","author":"Kusuhara","year":"2009","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2017.11.001_bb0310","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3109\/13880209.2014.900809","article-title":"Interactions of the active components of Punica Granatum (pomegranate) with the essential renal and hepatic human solute carrier transporters","volume":"52","author":"Li","year":"2014","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0315","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.numecd.2014.08.006","article-title":"Uric acid promotes chemokine and adhesion molecule production in vascular endothelium via nuclear factor-kappa B signaling","volume":"25","author":"Liang","year":"2015","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.ejps.2017.11.001_bb0320","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0022-3565(24)39100-1","article-title":"Hydroxyprolylserine derivatives JBP923 and JBP485 exhibit the antihepatitis activities after gastrointestinal absorption in rats","volume":"294","author":"Liu","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.11.001_bb0325","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.taap.2012.08.019","article-title":"Changes in expression of renal Oat1, Oat3 and Mrp2 in cisplatin-induced acute renal failure after treatment of JBP485 in rats","volume":"264","author":"Liu","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0330","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s11095-013-1235-9","article-title":"MDR1 and OAT1\/OAT3 mediate the drug-drug interaction between puerarin and methotrexate","volume":"31","author":"Liu","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2017.11.001_bb0335","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0033-1360127","article-title":"Betaine reduces serum uric acid levels and improves kidney function in hyperuricemic mice","volume":"80","author":"Liu","year":"2014","journal-title":"Planta Med."},{"key":"10.1016\/j.ejps.2017.11.001_bb0340","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1681\/ASN.2014080793","article-title":"EGF receptor inhibition alleviates Hyperuricemic nephropathy","volume":"26","author":"Liu","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0345","doi-asserted-by":"crossref","first-page":"F1351","DOI":"10.1152\/ajprenal.00055.2016","article-title":"The rebirth of interest in renal tubular function","volume":"310","author":"Lowenstein","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0350","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jep.2014.03.055","article-title":"Interaction of five anthraquinones from rhubarb with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8) and drug-drug interaction in rats","volume":"153","author":"Ma","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0355","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejps.2014.04.004","article-title":"Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans","volume":"59","author":"Maeda","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.11.001_bb0360","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-physiol-021113-170343","article-title":"The molecular physiology of uric acid homeostasis","volume":"77","author":"Mandal","year":"2015","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0365","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pharmthera.2010.02.007","article-title":"Therapeutic implications of renal anionic drug transporters","volume":"126","author":"Masereeuw","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2017.11.001_bb0370","series-title":"Quantitative Prediction of Human Renal Clearance and Drug-Drug Interactions of Organic Anion Transporter Substrates Using In Vitro Transport Data","author":"Mathialagan","year":"2017"},{"key":"10.1016\/j.ejps.2017.11.001_bb0375","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s12325-015-0272-7","article-title":"Management of Chronic Kidney Disease: the relationship between serum uric acid and development of nephropathy","volume":"32","author":"Mende","year":"2015","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejps.2017.11.001_bb0380","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2174\/1389200216666150223152348","article-title":"Pharmacokinetic interactions between herbal medicines and prescribed drugs: focus on drug metabolic enzymes and transporters","volume":"15","author":"Meng","year":"2014","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejps.2017.11.001_bb0385","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejps.2012.11.008","article-title":"Inhibitory effect of 1alpha,25-dihydroxyvitamin D(3) on excretion of JBP485 via organic anion transporters in rats","volume":"48","author":"Miao","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.11.001_bb0390","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1681\/ASN.2005030306","article-title":"Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins","volume":"16","author":"Miyazaki","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0395","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00000441-200504000-00009","article-title":"Mizoribine-induced rhabdomyolysis in a rheumatoid arthritis patient receiving bezafibrate treatment","volume":"329","author":"Morimoto","year":"2005","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ejps.2017.11.001_bb0400","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-pharmtox-011112-140317","article-title":"Renal transporters in drug development","volume":"53","author":"Morrissey","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0405","series-title":"Effects of Proton Pump Inhibitors and Famotidine on Elimination of Plasma Methotrexate: Evaluation of Drug-Drug Interactions Mediated by Organic Anion Transporter 3","author":"Narumi","year":"2017"},{"key":"10.1016\/j.ejps.2017.11.001_bb0410","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1124\/dmd.111.039115","article-title":"Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats","volume":"39","author":"Naud","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.11.001_bb0415","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/1389450033491028","article-title":"Di\/tri-peptide transporters as drug delivery targets: regulation of transport under physiological and patho-physiological conditions","volume":"4","author":"Nielsen","year":"2003","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejps.2017.11.001_bb0420","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2215\/CJN.02440314","article-title":"Handling of drugs, metabolites, and uremic toxins by kidney proximal tubule drug transporters","volume":"10","author":"Nigam","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0425","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1097\/CCM.0b013e318168e375","article-title":"An overview of drug-induced acute kidney injury","volume":"36","author":"Pannu","year":"2008","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejps.2017.11.001_bb0430","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1124\/dmd.108.020917","article-title":"Rate-limiting steps in hepatic drug clearance: comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir","volume":"36","author":"Parker","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.11.001_bb0435","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/B978-0-12-800223-0.00006-2","article-title":"SLC22, SLC44, and SLC47 transporters--organic anion and cation transporters: molecular and cellular properties","volume":"73","author":"Pelis","year":"2014","journal-title":"Curr. Top. Membr."},{"key":"10.1016\/j.ejps.2017.11.001_bb0440","doi-asserted-by":"crossref","DOI":"10.1038\/srep16226","article-title":"Green tea inhibited the elimination of nephro-cardiovascular toxins and deteriorated the renal function in rats with renal failure","volume":"5","author":"Peng","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2017.11.001_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000430328","article-title":"Regulation of expression of renal organic anion transporters OAT1 and OAT3 in a model of ischemia\/reperfusion injury","volume":"37","author":"Preising","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejps.2017.11.001_bb0450","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/nep.12002","article-title":"Renal impairment among acute hospital admissions in a rural Ethiopian hospital","volume":"18","author":"Riley","year":"2013","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ejps.2017.11.001_bb0455","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2174\/0929867323666160112122858","article-title":"Molecular dissection of renal ischemia-reperfusion: oxidative stress and cellular events","volume":"23","author":"Rovcanin","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejps.2017.11.001_bb0460","first-page":"1073","article-title":"Meclofenamate elicits a nephropreventing effect in a rat model of ischemic acute kidney injury by suppressing indoxyl sulfate production and restoring renal organic anion transporters","volume":"8","author":"Saigo","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ejps.2017.11.001_bb0465","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/toxsci\/kfu119","article-title":"Hepatic sulfotransferase as a nephropreventing target by suppression of the uremic toxin indoxyl sulfate accumulation in ischemic acute kidney injury","volume":"141","author":"Saito","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejps.2017.11.001_bb0470","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2133\/dmpk.DMPK-13-NT-070","article-title":"A common variant of organic anion transporter 4 (OAT4\/SLC22A11) gene is associated with renal underexcretion type gout","volume":"29","author":"Sakiyama","year":"2014","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2017.11.001_bb0475","first-page":"3807","article-title":"Delayed elimination of methotrexate associated with co-administration of proton pump inhibitors","volume":"30","author":"Santucci","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejps.2017.11.001_bb0480","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11095-007-9401-6","article-title":"Involvement of uric acid transporters in alteration of serum uric acid level by angiotensin II receptor blockers","volume":"25","author":"Sato","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2017.11.001_bb0485","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1248\/bpb.33.498","article-title":"Renal secretion of uric acid by organic anion transporter 2 (OAT2\/SLC22A7) in human","volume":"33","author":"Sato","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejps.2017.11.001_bb0490","doi-asserted-by":"crossref","first-page":"F198","DOI":"10.1152\/ajprenal.00160.2014","article-title":"Oat1\/3 restoration protects against renal damage after ischemic AKI","volume":"308","author":"Schneider","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0495","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.ackd.2016.01.016","article-title":"Drug transporter function--implications in CKD","volume":"23","author":"Schwenk","year":"2016","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.ejps.2017.11.001_bb0500","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1517\/13543784.2015.1051617","article-title":"Investigational drugs for hyperuricemia","volume":"24","author":"Shahid","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejps.2017.11.001_bb0505","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/mnfr.201100828","article-title":"Antihyperuricemic and nephroprotective effects of resveratrol and its analogues in hyperuricemic mice","volume":"56","author":"Shi","year":"2012","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejps.2017.11.001_bb0510","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jep.2012.08.023","article-title":"Uricosuric and nephroprotective properties of Ramulus Mori ethanol extract in hyperuricemic mice","volume":"143","author":"Shi","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0515","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1159\/000350077","article-title":"Regulation of renal organic anion transporter 3 (SLC22A8) expression and function by the integrity of lipid raft domains and their associated cytoskeleton","volume":"31","author":"Srimaroeng","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejps.2017.11.001_bb0520","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1124\/dmd.114.059873","article-title":"Role of (drug) transporters in imaging in health and disease","volume":"42","author":"Stieger","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.11.001_bb0525","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/cpt.406","article-title":"Pharmacokinetic evaluation of a drug transporter cocktail consisting of digoxin, furosemide, metformin, and Rosuvastatin","volume":"100","author":"Stopfer","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2017.11.001_bb0530","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jep.2014.12.001","article-title":"Effects of Xie-Zhuo-Chu-bi-fang on miR-34a and URAT1 and their relationship in hyperuricemic mice","volume":"161","author":"Sun","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0535","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2125.2008.03303.x","article-title":"Co-administration of proton pump inhibitors delays elimination of plasma methotrexate in high-dose methotrexate therapy","volume":"67","author":"Suzuki","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0540","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.nucmedbio.2013.03.006","volume":"40","author":"Takahara","year":"2013","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0545","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1124\/dmd.116.071472","article-title":"Investigation of endogenous compounds applicable to drug-drug interaction studies involving the renal organic anion transporters, OAT1 and OAT3, in humans","volume":"44","author":"Tsuruya","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.11.001_bb0550","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1208\/s12248-012-9413-y","article-title":"Renal organic anion transporters (SLC22 family): expression, regulation, roles in toxicity, and impact on injury and disease","volume":"15","author":"Wang","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2017.11.001_bb0555","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.peptides.2011.01.031","article-title":"Effects of JBP485 on the expression and function of PEPT1 in indomethacin-induced intestinal injury in rats and damage in Caco-2 cells","volume":"32","author":"Wang","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.ejps.2017.11.001_bb0560","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jchromb.2013.08.024","article-title":"Simultaneous determination of gallic acid and gentisic acid in organic anion transporter expressing cells by liquid chromatography-tandem mass spectrometry","volume":"937","author":"Wang","year":"2013","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ejps.2017.11.001_bb0565","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bcp.2013.08.016","article-title":"The anthraquinone drug rhein potently interferes with organic anion transporter-mediated renal elimination","volume":"86","author":"Wang","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0570","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1124\/dmd.113.055194","article-title":"Aspirin and probenecid inhibit organic anion transporter 3-mediated renal uptake of cilostazol and probenecid induces metabolism of cilostazol in the rat","volume":"42","author":"Wang","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.11.001_bb0575","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejps.2014.06.019","article-title":"PEPT1- and OAT1\/3-mediated drug-drug interactions between bestatin and cefixime in vivo and in vitro in rats, and in vitro in human","volume":"63","author":"Wang","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.11.001_bb0580","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.taap.2014.03.013","article-title":"Dioscin enhances methotrexate absorption by down-regulating MDR1 in vitro and in vivo","volume":"277","author":"Wang","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0585","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2014.11.035","article-title":"Nuciferine restores potassium oxonate-induced hyperuricemia and kidney inflammation in mice","volume":"747","author":"Wang","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0590","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bcp.2015.11.024","article-title":"Serum- and glucocorticoid-inducible kinase SGK2 regulates human organic anion transporters 4 via ubiquitin ligase Nedd4-2","volume":"102","author":"Wang","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0595","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/jcb.25407","article-title":"Resveratrol increases anti-proliferative activity of Bestatin through downregulating P-glycoprotein expression via inhibiting PI3K\/Akt\/mTOR pathway in K562\/ADR cells","volume":"117","author":"Wang","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejps.2017.11.001_bb0600","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.biopha.2016.07.025","article-title":"Astilbin improves potassium oxonate-induced hyperuricemia and kidney injury through regulating oxidative stress and inflammation response in mice","volume":"83","author":"Wang","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ejps.2017.11.001_bb0605","first-page":"499","article-title":"Siwu decoction attenuates oxonate-induced hyperuricemia and kidney inflammation in mice","volume":"14","author":"Wang","year":"2016","journal-title":"Anat. Sci. Int."},{"key":"10.1016\/j.ejps.2017.11.001_bb0610","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s10157-013-0902-9","article-title":"Human organic anion transporters function as a high-capacity transporter for p-cresyl sulfate, a uremic toxin","volume":"18","author":"Watanabe","year":"2014","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0615","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035556","article-title":"Male-dominant activation of rat renal organic anion transporter 1 (Oat1) and 3 (Oat3) expression by transcription factor BCL6","volume":"7","author":"Wegner","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2017.11.001_bb0620","doi-asserted-by":"crossref","first-page":"F1283","DOI":"10.1152\/ajprenal.00426.2014","article-title":"Transcriptional regulation of human organic anion transporter 1 by B-cell CLL\/lymphoma 6","volume":"307","author":"Wegner","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0625","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/mnfr.201000652","article-title":"Interaction of hydroxycinnamic acids and their conjugates with organic anion transporters and ATP-binding cassette transporters","volume":"55","author":"Wong","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejps.2017.11.001_bb0630","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.bcp.2011.01.004","article-title":"Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1\/SLC22A6","volume":"81","author":"Wong","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0635","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/ptr.5207","article-title":"Effects of Smilaxchinoside a and Smilaxchinoside C, two steroidal glycosides from Smilax Riparia, on hyperuricemia in a mouse model","volume":"28","author":"Wu","year":"2014","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ejps.2017.11.001_bb0640","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1142\/S0192415X14200018","article-title":"Smilax Riparia reduces hyperuricemia in mice as a potential treatment of gout","volume":"42","author":"Wu","year":"2014","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.ejps.2017.11.001_bb0645","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.phymed.2014.03.009","article-title":"Riparoside B and timosaponin J, two steroidal glycosides from Smilax Riparia, resist to hyperuricemia based on URAT1 in hyperuricemic mice","volume":"21","author":"Wu","year":"2014","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejps.2017.11.001_bb0650","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jep.2015.01.012","article-title":"Anti-hyperuricemia effects of allopurinol are improved by Smilax Riparia, a traditional Chinese herbal medicine","volume":"162","author":"Wu","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0655","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ejps.2012.12.024","article-title":"OAT1 and OAT3: targets of drug-drug interaction between entecavir and JBP485","volume":"48","author":"Xu","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.11.001_bb0660","doi-asserted-by":"crossref","first-page":"F320","DOI":"10.1152\/ajprenal.00153.2016","article-title":"The role of Nedd4-1 WW domains in binding and regulating human organic anion transporter 1","volume":"311","author":"Xu","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0665","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1021\/acs.molpharmaceut.5b00839","article-title":"An essential role of Nedd4-2 in the ubiquitination, expression, and function of organic anion Transporter-3","volume":"13","author":"Xu","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2017.11.001_bb0670","doi-asserted-by":"crossref","first-page":"F821","DOI":"10.1152\/ajprenal.00522.2015","article-title":"Nedd4-2 but not Nedd4-1 is critical for protein kinase C-regulated ubiquitination, expression, and transport activity of human organic anion transporter 1","volume":"310","author":"Xu","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0675","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1021\/mp100418u","article-title":"Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I","volume":"8","author":"Xue","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2017.11.001_bb0680","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/jbt.21435","article-title":"Endocrine and metabolic regulation of renal drug transporters","volume":"26","author":"Yacovino","year":"2012","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0685","doi-asserted-by":"crossref","first-page":"806","DOI":"10.2174\/1389200217666160629112717","article-title":"P-gp inhibition-based strategies for modulating pharmacokinetics of anticancer drugs: an update","volume":"17","author":"Yang","year":"2016","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejps.2017.11.001_bb0690","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/toxsci\/kfq219","article-title":"Characterization of cellular uptake of perfluorooctanoate via organic anion-transporting polypeptide 1A2, organic anion transporter 4, and urate transporter 1 for their potential roles in mediating human renal reabsorption of perfluorocarboxylates","volume":"117","author":"Yang","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejps.2017.11.001_bb0695","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1248\/bpb.b15-00402","article-title":"Mangiferin inhibits renal urate reabsorption by modulating urate transporters in experimental hyperuricemia","volume":"38","author":"Yang","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejps.2017.11.001_bb0700","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ejps.2012.06.004","article-title":"Inhibitory effect of JBP485 on renal excretion of acyclovir by the inhibition of OAT1 and OAT3","volume":"47","author":"Ye","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.11.001_bb0705","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.apsb.2016.07.013","article-title":"Renal drug transporters and their significance in drug-drug interactions","volume":"6","author":"Yin","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejps.2017.11.001_bb0710","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1124\/jpet.108.149476","article-title":"Renal organic anion transporter-mediated drug-drug interaction between gemcabene and quinapril","volume":"330","author":"Yuan","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.11.001_bb0715","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1124\/dmd.110.032060","article-title":"Pharmacokinetic interaction between JBP485 and cephalexin in rats","volume":"38","author":"Zhang","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2017.11.001_bb0720","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.mce.2013.04.027","article-title":"Uric acid induces oxidative stress and growth inhibition by activating adenosine monophosphate-activated protein kinase and extracellular signal-regulated kinase signal pathways in pancreatic beta cells","volume":"375","author":"Zhang","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejps.2017.11.001_bb0725","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1039\/C5FO00499C","article-title":"Effects of anthocyanins from purple sweet potato (Ipomoea Batatas L. cultivar Eshu no. 8) on the serum uric acid level and xanthine oxidase activity in hyperuricemic mice","volume":"6","author":"Zhang","year":"2015","journal-title":"Food Funct."},{"key":"10.1016\/j.ejps.2017.11.001_bb0730","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1128\/AAC.02414-14","article-title":"Effects of renal impairment on the pharmacokinetics of morinidazole: uptake transporter-mediated renal clearance of the conjugated metabolites","volume":"58","author":"Zhong","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2017.11.001_bb0735","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11095-006-9144-9","article-title":"Molecular insights into the structure-function relationship of organic anion transporters OATs","volume":"24","author":"Zhou","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2017.11.001_bb0740","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1055\/s-0034-1383048","article-title":"Total saponins from Discorea nipponica ameliorate urate excretion in hyperuricemic mice","volume":"80","author":"Zhou","year":"2014","journal-title":"Planta Med."},{"key":"10.1016\/j.ejps.2017.11.001_bb0745","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.peptides.2012.01.007","article-title":"Organic anion transporters involved in the excretion of bestatin in the kidney","volume":"33","author":"Zhu","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.ejps.2017.11.001_bb0750","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijpharm.2014.02.020","article-title":"Methotrexate-bestatin interaction: involvement of P-glycoprotein and organic anion transporters in rats","volume":"465","author":"Zhu","year":"2014","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717306206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717306206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T22:46:04Z","timestamp":1750977964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717306206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":150,"alternative-id":["S0928098717306206"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.11.001","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal organic anion transporters in drug\u2013drug interactions and diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}